Free shipping on all orders over $ 500

Danicamtiv (MYK-491)

Cat. No. M21004

All AbMole products are for research use only, cannot be used for human consumption.

Danicamtiv (MYK-491) Structure
Synonym:

SAR 440181; MYK491

Size Price Availability Quantity
1mg USD 152 In stock
5mg USD 288 In stock
10mg USD 464 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Danicamtiv (MYK-491, SAR 440181) is a novel and selective cardiac myosin allosteric activator that enhances cardiomyocyte contraction. Danicamtiv selectively enhances cardiac actomyosin activity, the molecular force‐generating unit of the sarcomere, prolonging contraction while preserving actin–myosin detachment, allowing relaxation, and without impacting Ca2+ homeostasis.

Chemical Information
Molecular Weight 435.42
Formula C16H20F3N5O4S
CAS Number 1970972-74-7
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Mark P Grillo, et al. Xenobiotica. Preclinical in vitro and in vivo pharmacokinetic properties of danicamtiv, a new targeted myosin activator for the treatment of dilated cardiomyopathy

Related Myosin Products
Omecamtiv mecarbil

Omecamtiv Mecarbil is a First-In-Class selective small molecule cardiac myosin activator that directly targets the contractile machinery of the heart, binding and increasing the number of cardiac myosin head regions interacting with actin during contraction.

(-)-Blebbistatin

(-)-Blebbistatin is a cell-permeable inhibitor for non muscle myosin II ATPase with IC50 of ~2 μM, does not inhibit myosin light chain kinase, inhibits contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly. *The compound is unstable in solutions, freshly prepared is recommended

2,3-Butanedione monoxime

2,3-Butanedione Monoxime (BDM) is a myosin ATPASE inhibitor. 2,3-Butanedione Monoxime is a skeletal and cardiac muscle contraction inhibitor. 2,3-Butanedione monoxime induces sarcoplasmic reticulum Ca2+ release.

TR100

TR100 is a specific anti-tropomyosin agent that preferentially disrupts the actin cytoskeleton of tumor cells. TR100 selectively disrupts Tm5NM1/2 containing actin filaments.

Blebbistain

(±)-Blebbistatin (BLEB) is a small cell permeable selective myosin II inhibitor which potently relaxed normal detrusor smooth muscle.

  Catalog
Abmole Inhibitor Catalog




Keywords: Danicamtiv (MYK-491), SAR 440181; MYK491 supplier, Myosin, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.